β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)

β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)

BackgroundThe prognostic impact of β‐blockers (BB) in acute coronary syndrome (ACS) patients without heart failure (HF) or left ventricular dysfunction is controversial, especially in the postreperfusion era. We sought to determine whether a BB therapy before admission for ACS has a favorable in‐hos...

Full description

Bibliographic Details
Main Authors: Charbel Abi Khalil, Khalid F. AlHabib, Rajvir Singh, Nidal Asaad, Hussam Alfaleh, Alawi A. Alsheikh‐Ali, Kadhim Sulaiman, Mostafa Alshamiri, Fayez Alshaer, Wael AlMahmeed, Jassim Al Suwaidi
Format: Article
Language:English
Published: Wiley 2017-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
β‐adrenergic receptor blocker
heart failure
ST‐segment elevation myocardial infarction
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007631

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.007631

Similar Items